
CVE · NYSE
Reports Oct 30, 2026.
Consensus is $1.07 EPS for Sep 2026 across 2 estimates, ranging $1.02 to $1.12.
Cenovus delivered a stronger operating quarter but no earnings surprise: Q2 EPS of $1.11 matched consensus. Net earnings of $2.9 billion increased from $851 million a year ago and $1.6 billion in Q1, while revenue rose 41% year over year to $17.4 billion from $12.4 billion in Q2 2025 and 41% sequentially from $12.4 billion. Adjusted Funds Flow of $5.0 billion was up from $1.5 billion a year ago and $3.4 billion in Q1.
The print was defined by commodity-price leverage, broad operating reliability and aggressive balance-sheet repair. Operating Margin reached $5.9 billion versus $2.1 billion a year ago, with upstream contributing $4.9 billion and downstream recovering to $953 million from a $71 million loss. Upstream production held near 1.0 MBOE/d, while refining benefited from stronger product pricing and crack spreads despite the Upgrader turnaround. Cenovus used the cash generation to repay its remaining $2.2 billion term loan, return $1.4 billion to shareholders and reduce net debt to $5.4 billion. Management raised midpoint production and throughput guidance, kept capital spending at $5.0-$5.3 billion, and maintained a late-Q3 first-oil target for West White Rose.